Abstract
To establish the usefulness of research of dispersion QT / QTc intervals and values of cardiac biomarkers-B natriuretic peptide (BNP) for early detection of cardiotoxicity in children with malignant diseases. Patients: 46 children (2 months-18 years), treated with anthracyclines for malignancies. Control group: 20 healthy children without cardiovascular history. Patients and controls were evaluated by clinical exam, surface 12 lead ECG (3 consecutive cycles of measuring the QT/QTc intervals and QT/QTc intervals dispersion), Doppler echocardiography (Echo), determining plasma levels of cardiac biomarkers BNP and cTnI. Were found some significant changes in patients comparativ with controls: *increasing the dispersion of the QT / QTc intervals (73% cases especially those with a cumulative dose of anthracyclines>250mg/m 2 and in patients with echo changes induced by anthracycline cardiotoxicity, even only with diastolic dysfunction of LV:- the mean of QT dispersion: 80 miliseconds in patients -40 millisec. in controls; - the mean QTc dispersion: 87,103 millisec. in patients-55.47 millisec in controls; ** Increased plasma levels of BNP in 45.7% of patients, from a mean baseline of 89 ng/ml to value 240 ng/ml. Biological changes were correlated with the presence of clinical manifestations, echo changes induced cardiotoxicity and increase of dispersion QT / QTc intervals. Conclusions. Increased levels of cardiac biomarkers: BNP and cTnI and of the dispersion of QT/QTc intervals in children treated with anthracyclines±other drugs with cardiotoxic efects positively correlates with installation of the cardiotoxicity with clinical or infraclinical manifestations, constituing an useful indicator for the cardiotoxicity. Changes in this parameters appeared early than echo changes anthracicline induced cardiotoxicity and is necessary to systematic monitoring these parameters during and after cyto-static treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.